GSA Capital Partners’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-20,722
| Closed | -$688K | – | 1912 |
|
|
2025
Q1 | $688K | Buy |
+20,722
| New | +$688K | 0.06% | 577 |
|
|
2024
Q4 | – | Sell |
-5,873
| Closed | -$235K | – | 1776 |
|
|
2024
Q3 | $235K | Buy |
+5,873
| New | +$235K | 0.02% | 1348 |
|
|
2023
Q4 | – | Sell |
-12,898
| Closed | -$423K | – | 1681 |
|
|
2023
Q3 | $423K | Buy |
12,898
+6,287
| +95% | +$206K | 0.04% | 895 |
|
|
2023
Q2 | $233K | Sell |
6,611
-42,151
| -86% | -$1.49M | 0.02% | 1184 |
|
|
2023
Q1 | $1.59M | Buy |
48,762
+19,618
| +67% | +$640K | 0.16% | 124 |
|
|
2022
Q4 | $1.61M | Buy |
29,144
+8,292
| +40% | +$457K | 0.2% | 52 |
|
|
2022
Q3 | $924K | Buy |
20,852
+16,045
| +334% | +$711K | 0.12% | 193 |
|
|
2022
Q2 | $234K | Sell |
4,807
-1,793
| -27% | -$87.3K | 0.04% | 975 |
|
|
2022
Q1 | $321K | Buy |
6,600
+1,563
| +31% | +$76K | 0.04% | 846 |
|
|
2021
Q4 | $215K | Buy |
+5,037
| New | +$215K | 0.03% | 1161 |
|